Treace Medical Concepts Analyst Price Targets

Wall Street analyst price targets and consensus rating for Treace Medical Concepts (TMCI).

Price Target Range — 10 Quarters

Analyst Consensus — 6 Analysts

1Buy

4Hold

1Sell

Consensus RatingNeutral# Analysts6Avg. Consensus PT$6Upside to Avg. PT+35.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 10, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$4→$5
Jul 16, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$2→$4
Mar 2, 2026	Lake Street	Ben Haynor	PT Cut	Buy	$8→$7
Jan 7, 2026	Stifel	Rick Wise	PT Cut	Hold	$5→$3
Dec 18, 2025	Truist Securities	Richard Newitter	PT Cut	Hold	$4→$3
Nov 10, 2025	Truist Securities	Richard Newitter	PT Cut	Hold	$7→$4
Nov 7, 2025	UBS	Danielle Antalffy	PT Cut	Neutral	$7→$6
Nov 7, 2025	JP Morgan	Lilia-Celine Lozada	Downgrade	Neutral→Underweight	$8→$5
Nov 7, 2025	BTIG	Ryan Zimmerman	Downgrade	Buy→Neutral	—
Oct 15, 2025	Truist Securities	Richard Newitter	PT Cut	Hold	$8→$7
Sep 4, 2025	Truist Securities	Richard Newitter	PT Raise	Hold	$7→$8
Aug 8, 2025	UBS	Danielle Antalffy	PT Cut	Neutral	$9→$7
Aug 8, 2025	Stifel	Rick Wise	PT Cut	Hold	$9→$6
May 9, 2025	UBS	Danielle Antalffy	PT Cut	Neutral	$10→$9
Apr 11, 2025	Truist Securities	Richard Newitter	PT Cut	Hold	$10→$8
Mar 13, 2025	Truist Securities	Richard Newitter	PT Cut	Hold	$10→$10
Mar 3, 2025	Truist Securities	Richard Newitter	PT Raise	Hold	$8→$10
Dec 31, 2024	Lake Street	Ben Haynor	Initiate	Buy	$15
Dec 18, 2024	Truist Securities	Richard Newitter	PT Raise	Hold	$7→$8
Dec 17, 2024	JP Morgan	Lilia-Celine Lozada	Assumes	Neutral	$8

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price target from $4 to $5.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price target from $2 to $4.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7

Lake Street analyst Ben Haynor maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and lowers the price target from $7.5 to $7.

Benzinga Newsdesk

The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts

Benzinga Insights

PRO
Stifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $5 to $3.

Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $4 to $3.

Benzinga Newsdesk

Treace Medical Concepts Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Treace Medical Concepts Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4

PRO
Lake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7

The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts

PRO
Stifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

People Also Watch

People Also Watch

Treace Medical Concepts Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Treace Medical Concepts Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROTruist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5

PROTruist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4

PROLake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7

The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts

PROStifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

PROTruist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

People Also Watch

People Also Watch

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4

PRO
Lake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7

PRO
Stifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3